TP53 and lip and oral cavity carcinoma: ∆Np63α functions as a dominant-negative inhibitor of p53, competing with its DNA-binding sites to promote oral cancer.73 Thus, the downregulation of ∆Np63α activates Wt-p53,15 further contributing to apoptosis and epithelial atrophy in OSF.